Researchers
Đoković, Nemanja
Results 1-20 of 59
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | A computational framework for the design and development of ERK2 and multi-target ERK2/HDAC inhibitors | Cebzan, Alen; Ružić, Dušan   ; Đoković, Nemanja ; Stanković, Branislav ; Nikolić, Katarina | Article | 21M21 |
| 2025 | Rational design of SIRT2 inhibitors: Integrating 3D-QSAR, molecular docking and machine learning techniques | Ilić, Aleksandra ; Đoković, Nemanja ; Đikić, Teodora ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2025 | P 01 Identification of Dual-Acting HDAC Inhibitors for Pancreatic Cancer Treatment through Drug Synergy Predictions and Molecular Modeling | Đoković, Nemanja ; Ilić, Aleksandra ; Čebzan, Alen ; Radović, Branko ; Ružić, Dušan ; Beljkaš, Milan ; Đurić, Ana ; Srdić-Rajić, Tatjana ; Oljačić, Slavica ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2025 | Computer-Aided Drug Design of novel dual histone deacetylase inhibitors | Ilić, Aleksandra ; Beljkaš, Milan ; Čebzan, Alen ; Radović, Branko ; Đoković, Nemanja ; Nikolić, Katarina ; Oljačić, Slavica | Conference Paper | Mp. category will be shown later |
| 2024 | Integration of 3D-QSAR, molecular docking, and machine learning techniques for rational design of nicotinamide-based SIRT2 inhibitors | Ilić, Aleksandra ; Đoković, Nemanja ; Đikić, Teodora ; Nikolić, Katarina | Article | 21M21 |
| 2024 | Molecular dynamics examination of the cryptic subpocket of sirtuin 2 | Đoković, Nemanja ; Marković, V; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2024 | Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modeling | Đoković, Nemanja ; Ilić, Aleksandra ; Čebzan, Alen ; Radović, Branko ; Ružić, Dušan ; Beljkaš, Milan ; Đurić, Ana ; Srdić-Rajić, Tatjana ; Oljačić, Slavica ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2024 | Molecular modeling and design of new PI3K/HDAC dual inhibitors | Beljkaš, Milan ; Kukić, E; Đoković, Nemanja ; Oljačić, Slavica | Conference Paper | Mp. category will be shown later |
| 2024 | Integrative Framework for Developing Innovative SIRT2 Inhibitors | Đoković, Nemanja ; Rahnasto‐Rilla, Minna; Đurić, Ana ; Ružić, Dušan ; Petković, Miloš ; Srdić Rajić, Tatjana ; Lahtela-Kakkonen, Maija; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2024 | Design and ADMET prediction of novel dual inhibitors from the histone deacetylase family | Ilić, Aleksandra ; Čebzan, Alen ; Radović, Branko ; Đoković, Nemanja ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2023 | Discovery of novel HDAC inhibitors for therapy of triple-negative breast cancer – preclinical study | Ružić, Dušan ; Đoković, Nemanja ; Santibanez, Juan ; Pavić, Aleksandar ; Ganesan, A.; Srdić- Rajić, Tatjana ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2023 | Reversible Control of RNA Splicing by Photoswitchable Small Molecules | Zhang, Lei; Xie, Xiulan; Đoković, Nemanja ; Nikolić, Katarina ; Kosenkov, Dmitri; Abendroth, Frank; Vázquez, Olalla | Article | 21a+M21a+ |
| 2023 | SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors | Đoković, Nemanja ; Rahnasto-Rilla, Minna; Lougiakis, Nikolas; Lahtela-Kakkonen, Maija; Nikolić, Katarina | Article | 21M21 |
| 2023 | Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer | Beljkas, Milan ; Ilić, Aleksandra ; Cebzan, Alen ; Radović, Branko ; Đoković, Nemanja ; Ružić, Dušan ; Nikolić, Katarina ; Oljačić, Slavica | Article | 21aM21a |
| 2023 | Simulacije molekulske dinamike, dizajn, sinteza i in vitro ispitivanje inhibitora epigenetskih proteina kao potencijalnih antineoplastika | Đoković, Nemanja | Doctoral theses | 70M70 |
| 2023 | Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinoma | Nemanja Djokovic ; Ana Djuric ; Dusan Ruzic ; Tatjana Srdic-Rajic ; Katarina Nikolic | Article | 21M21 |
| 2023 | Towards the multitarget HDAC Inhibitors for the treatment of pancreatic carcinoma by joining the drug synergy predictions and the molecular modeling | Đoković, Nemanja ; Ilić, Aleksandra ; Čebzan, Alen ; Radović, Branko ; Ružić, Dušan ; Đurić, Ana ; Srdić-Rajić, Tatjana ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention | Ružić, Dušan ; Đoković, Nemanja ; Srdić-Rajić, Tatjana ; Echeverria, Cesar; Nikolić, Katarina ; Santibanez, Juan | Article | 21aM21a |
| 2022 | Epigenetic drug discovery: fragment-based drug design of novel 1-benzhydryl-piperazine derivatives as selective histone deacetylase 6 inhibitors | Ružić, Dušan ; Đoković, Nemanja ; Srdić-Rajić, Tatjana ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation | Ružić, Dušan ; Ellinger, Bernhard; Đoković, Nemanja ; Santibanez, Juan ; Gul, Sheraz; Beljkaš, Milan ; Đurić, Ana ; Ganesan, Arasu; Pavić, Aleksandar ; Srdić-Rajić, Tatjana ;
Petković, Miloš
; Nikolić, Katarina ; | Article | 21aM21a |